Novo Nordisk ٦ مايو ٢٠٢٦ French regulator fines Novo, Lilly over obesity drug promotion - Fierce Pharma
Novo Nordisk ٦ مايو ٢٠٢٦ Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price - statnews.com
Novo Nordisk ٦ مايو ٢٠٢٦ ‘No change’ for CagriSema as Novo ditches single-chamber device - Fierce Biotech
Novo Nordisk ٥ مايو ٢٠٢٦ Novo Nordisk, Eli Lilly Penalised in France for Indirect Promotion of Obesity Drugs - Medical Dialogues
Novo Nordisk ٥ مايو ٢٠٢٦ Analysts predict Novo Nordisk adjustment after strong Wegovy launch - medwatch.com
Novo Nordisk ٤ مايو ٢٠٢٦ Novo Nordisk Rebrands Rybelsus as Ozempic Pills to Strengthen US Position - Medical Dialogues
Novo Nordisk ٤ مايو ٢٠٢٦ Novo Nordisk relaunches diabetes pill in the US under Ozempic brand - medwatch.com
Novo Nordisk ٢ مايو ٢٠٢٦ FDA Proposal Could Support Novo Nordisk GLP‑1 Exclusivity And Valuation - simplywall.st
Novo Nordisk ١ مايو ٢٠٢٦ Danish biotech firm Zealand Pharma proposes former Novo Nordisk senior to board - marketscreener.com
Novo Nordisk ١ مايو ٢٠٢٦ Novo Nordisk’s Rybelsus officially retired in US as ‘Ozempic pill’ takes branding center stage - Fierce Pharma
Novo Nordisk ١ مايو ٢٠٢٦ Lexicon Pharma (LXRX), Novo Nordisk (NVO) Initiate Phase 1 Study for Obesity Drug LX9851 - Yahoo Finance
Novo Nordisk ١ مايو ٢٠٢٦ Novo Nordisk weight-loss pill sees drop in new US prescriptions - medwatch.com
Novo Nordisk ١ مايو ٢٠٢٦ A proposal seeks to remove Novo and Lilly drugs from key list in the US – will provide better protection against copies - medwatch.com
Novo Nordisk ٣٠ أبريل ٢٠٢٦ Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO - Bloomberg.com
Novo Nordisk ٣٠ أبريل ٢٠٢٦ Is Novo Nordisk's GLP-1 dominance fading after Lilly's clinical wins? - MSN